The following pages link to (Q5434036):
Displaying 12 items.
- The treatment versus experimentation dilemma in dose finding studies (Q538132) (← links)
- Optimal Bayesian-feasible dose escalation for cancer phase I trials (Q1265963) (← links)
- Bayesian hierarchical random-effects meta-analysis and design of phase I clinical trials (Q2080762) (← links)
- Random-effects meta-analysis of phase I dose-finding studies using stochastic process priors (Q2233150) (← links)
- An application of reinforced urn processes to determining maximum tolerated dose (Q2373664) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Bayesian dose finding for combined drugs with discrete and continuous doses (Q2633955) (← links)
- Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design (Q4796210) (← links)
- Dose Finding – A Challenge in Statistics (Q5123082) (← links)
- Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials (Q5254712) (← links)
- DICE: A Bayesian model for early dose finding in phase I trials with multiple treatment courses (Q6068878) (← links)
- Bayesian dose regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics (Q6079344) (← links)
